Mallinckrodt Hospital Products IP Unlimited – Trademark Portfolio

Entity Type: 79

Mallinckrodt Hospital Products IP Unlimited holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include EVOLVE. The owner is based in Dublin 15.

College Business & Technology Park

Cruiserath Road, Blanchardstown

Dublin 15 D15TX2V , IE

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EVOLVE
EVOLVE
Registered 2021

Trademark Classifications

Mallinckrodt Hospital Products IP Unlimited's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Mallinckrodt Hospital Products IP Unlimited have?

Mallinckrodt Hospital Products IP Unlimited has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Mallinckrodt Hospital Products IP Unlimited file in?

Mallinckrodt Hospital Products IP Unlimited files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Mallinckrodt Hospital Products IP Unlimited's most well-known trademarks?

Mallinckrodt Hospital Products IP Unlimited's registered trademark portfolio includes well-known marks such as EVOLVE. These are among 1 currently registered trademark in the portfolio.

What is Mallinckrodt Hospital Products IP Unlimited's trademark registration success rate?

Mallinckrodt Hospital Products IP Unlimited has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.